Cargando…

Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis

BACKGROUND: Glasgow prognostic score (GPS) is widely known as a systemic inflammatory-based marker. The relationship between pretreatment GPS and gastric cancer (GC) survival and clinicopathological features remains controversial. The aim of the study was to conduct a meta-analysis of published stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chun-Xiao, Wang, Shu-Yi, Chen, Shuang-Qian, Yang, Shuai-Long, Wan, Lu, Xiong, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930270/ https://www.ncbi.nlm.nih.gov/pubmed/27390529 http://dx.doi.org/10.2147/OTT.S103996

Ejemplares similares

Pretreatment Modified Glasgow Prognostic Score for Predicting Prognosis and Survival in Elderly Patients with Gastric Cancer Treated with Perioperative FLOT
por: Melekoglu, Ebru, et al.
Publicado: (2023)

Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score
por: Hirahara, Noriyuki, et al.
Publicado: (2020)

Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumab-treated patients with advanced gastric cancer
por: Tokuyama, Nagahiro, et al.
Publicado: (2021)

A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
por: Tong, Tongyu, et al.
Publicado: (2020)

Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer
por: Minami, Seigo, et al.
Publicado: (2017)

The prognostic value of pretreatment Glasgow Prognostic Score in patients with esophageal cancer: a meta-analysis
por: Wang, Yan, et al.
Publicado: (2019)

Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
por: Lu, Lingling, et al.
Publicado: (2021)

The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9
por: Zhang, Shun, et al.
Publicado: (2022)

Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis
por: Xie, Yulian, et al.
Publicado: (2023)

Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer
por: Jiang, X, et al.
Publicado: (2012)

The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma
por: Xu, Bin, et al.
Publicado: (2021)

The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma
por: Tian, Rui, et al.
Publicado: (2016)

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
por: Kinoshita, Akiyoshi, et al.
Publicado: (2013)

Is the Glasgow Prognostic Score Applicable to Both Early- and Advanced-Stage Gastric Cancers?
por: Wakahara, Tomoyuki, et al.
Publicado: (2017)

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer
por: Wasamoto, Satoshi, et al.
Publicado: (2023)

Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis
por: Lin, Jian-Xian, et al.
Publicado: (2019)

Significance of the Glasgow Prognostic Score in Predicting the Postoperative Outcome of Patients with Stage III Gastric Cancer
por: Hsueh, Shun-Wen, et al.
Publicado: (2019)

The clinicopathological features and prognostic factors of gastric squamous cell carcinoma
por: Dong, Caixia, et al.
Publicado: (2016)

Clinicopathological Features and Prognostic Implication of Gastric Carcinoma with Lymphoid Stroma
por: Pyo, Jung-Soo, et al.
Publicado: (2020)

Postoperative survival According to the Glasgow Prognostic Score in Patients with Resected Lung Adenocarcinoma
por: Machida, Yuichiro, et al.
Publicado: (2016)

The application of the Glasgow prognostic score to predict the survival in patients with metastatic pancreatic carcinoma
por: Mohammed, Amrallah A., et al.
Publicado: (2022)

The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer
por: Kasajima, Masashi, et al.
Publicado: (2023)

Clinicopathological Features and Prognostic Outcomes of Papillary Renal Cell Carcinoma
por: Qian, Xiaoyuan, et al.
Publicado: (2021)

Proposal for a clinicopathological prognostic score for resected gastric cancer patients
por: Díaz del Arco, Cristina, et al.
Publicado: (2020)

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer
por: Hanai, Nobuhiro, et al.
Publicado: (2018)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

Impact of Age on Clinicopathological Features and Survival of Patients with Noncardia Gastric Adenocarcinoma
por: Bautista, Marita C, et al.
Publicado: (2014)

Clinicopathological Features and Postoperative Survival Analysis of Gastric Carcinoma with Neuroendocrine Differentiation
por: Liu, Jin, et al.
Publicado: (2022)

Clinicopathological features and prognostic analysis of signet ring cell gastric carcinoma: a population-based study
por: Guo, Shuai, et al.
Publicado: (2019)

Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer
por: Pan, Mingmei, et al.
Publicado: (2021)

Assessing Epstein–Barr virus in gastric cancer: clinicopathological features and prognostic implications
por: Li, Guanghua, et al.
Publicado: (2023)

The Modified Glasgow Prognostic Score as a Predictor of Survival After Hepatectomy for Colorectal Liver Metastases
por: Nakagawa, Kazuya, et al.
Publicado: (2014)

The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients
por: Cho, Anna, et al.
Publicado: (2020)

Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score
por: Draeger, Desiree-Louise, et al.
Publicado: (2023)

Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer
por: Li, Yu-Ting, et al.
Publicado: (2022)

Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival
por: Turkoz, Fatma Paksoy, et al.
Publicado: (2014)

The Glasgow Prognostic Score Before Curative Resection May Predict Postoperative Complications in Patients with Gastric Cancer
por: Shimoda, Yota, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer
por: Gu, Xiaobin, et al.
Publicado: (2016)

Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma
por: Hao, Xiaoxiao, et al.
Publicado: (2017)

Staging the Tumor and Staging the Host: Pretreatment Combined Neutrophil Lymphocyte Ratio and Modified Glasgow Prognostic Score Is Associated with Overall Survival in Patients with Esophagogastric Cancers Undergoing Treatment with Curative Intent
por: McSorley, Stephen T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7djvqhpk1a9kp0oqpej5dm83ls